Giving patients drugs that are based on the active
ingredient in magic mushrooms, known for their hallucinogenic properties, could help reboot the brains of people who suffer from mental illness and who are otherwise resistant to treatment.
Psilocybin, a hallucinogenic compound
found in magic mushrooms, may help re-set the activity of neural circuits in the brain that are involved in depression
New research, published in Human Brain Mapping, has examined the brain effects of the psychedelic
chemical in magic mushrooms, called psilocybin, using data from brain scans of volunteers who had been injected with the drug.
Psilocybin, the active
ingredient in magic mushrooms, is being explored as a therapeutic tool to improve the lives of people with a life - threatening illness
Two long - awaited studies test efficacy of psilocybin, the hallucinogenic compound in magic mushrooms
Kometer and his team gave 50 people a moderate dose of psilocybin, the hallucinogen
found in magic mushrooms that's known to induce spiritual experiences.
Psilocybin, a compound
in magic mushrooms, may help treat depression in some people.
THE PROBLEM After psilocybin, the active ingredient
in magic mushrooms, was outlawed in the mid-1960s, hallucinogen researchers quit cold turkey.
One of the most reliable — and reversible — ways to alter your sense of self is to ingest psychedelic drugs such as LSD or psilocybin, the active ingredient
in magic mushrooms.
Two long - awaited studies suggest that the hallucinogenic compound
in magic mushrooms, psilocybin, could do just that.
Cancer patients in two new studies felt less depressed after taking psilocybin, the hallucinogenic compound
in magic mushrooms.
Psilocybin, the active compound
in magic mushrooms, could make people feel more connected to nature and...